the market?
Bristol-Myers Squibb Co.
NYSE: BMY
47.40
0.40
(0.85%)
Extended Hours:
$47.43
$0.03
(0.06%)
| Today's Open | $46.56 |
|---|---|
| Previous Close | $47.00 |
| Daily Range | $45.81 - $47.55 |
| 52-Week Range | $30.64 - $47.55 |
| Market Cap | $77.9B |
| P/E Ratio | 52.81 |
| Dividend (Yield) | $1.40 (3.0%) |
| Ex-Dividend Date Dividend Pay Date |
04/03/13 05/01/13 |
| Volume | 12,236,746 |
| Average Daily Volume | 11,149,417 |
| Current FY EPS | $1.81 |
How do you think BMY
will perform against the market?
Top BMY Bull/Bear Pitches
News & Commentary
Why Immunotherapy Stocks Could Be Set for a Big Move
The American Society of Clinical Oncology's annual meeting kicks off late next week, and this group of stocks looks primed to impress analysts and investors alike.Wall Street Loves this New Immunotherapy Cancer Drug
Bristol-Myers Squibb gets a huge upgrade on the back of cancer-fighting immunotherapy drug nivolumab.Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.Stock Upgrades: Dice Holdings Is on a Roll
Wall Street ratings agencies set the tone for today's stock market.The Top 3 Diseases Caused by Stress
Not all stress is bad; but for those who are overstressed, these three diseases could be the end result.Will Amgen's Novel Drug Revolutionize Cancer Treatment?
A new first-of-its-kind immunotherapy trains the immune system to target cancer cells. Can it revolutionize cancer treatment for good?Sector
Healthcare
Industry
Drugs
Bristol-Myers Squibb Co. (BMY) Description
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/
CEO Rating by Glassdoor
More details for Bristol-Myers Squibb Jobs
Bristol-Myers Squibb reviews from employees
